Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HEALTHEQUITY, INC.
Report date September 20, 2021 · Filed September 21, 2021
Section 16 reporting ended · disclosed 2021-09-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,052 |
Ending reported balance
After 2021-09-20 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-09-20 · Exercise / conversion · Acquired 10,000 · Balance 97,052 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Row 2 · 2021-09-20 · Sale · Disposed 5,665 · Balance 91,387 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Row 3 · 2021-09-20 · Sale · Disposed 335 · Balance 91,052 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2024-07-30 | Direct | 20,000 |
Reported balance
After 2021-09-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-09-20 · Exercise / conversion · Disposed 10,000 · Balance 20,000 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.39 · Expires 2025-03-26 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 25,000 F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.28 · Expires 2027-03-27 | Direct | 19,897 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 19,897 F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.72 · Expires 2028-03-27 | Direct | 14,228 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 14,228 F4: The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.61 · Expires 2029-03-26 | Direct | 15,337 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 15,337 F5: The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3: The option is immediately exercisable.
F4: The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
F5: The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2017 Filed Oct 24, 2017 13:19 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $49.90 | $474,020.55 |
DisclosureSEC source: 0001140361-17-039367 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.58 to $50.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 13:19 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001140361-17-039367 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| September 20, 2017 Filed Sep 22, 2017 19:51 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-036259 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| September 20, 2017 Filed Sep 22, 2017 19:51 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $46.79 | $444,503.10 |
DisclosureSEC source: 0001140361-17-036259 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.51 to $47.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 20, 2017 Filed Sep 22, 2017 19:51 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001140361-17-036259 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-033130 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $42.00 | $398,956.30 |
DisclosureSEC source: 0001140361-17-033130 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.78 to $42.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001140361-17-033130 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 18:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-17-016607 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 18:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $43.44 | $434,447.00 |
DisclosureSEC source: 0001140361-17-016607 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 18:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-17-016607 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:11 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-17-013838 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 20,000 shares Expires 2024-07-30 F2 · shares: On June 30, 2014, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2017 were met, resulting in the vesting of the option as to 20,000 shares. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:11 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 19,897 | $0.00 Strike: $41.28 | $0.00 |
DisclosureSEC source: 0001140361-17-013838 · doc1.xml · derivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,897 Underlying: Common Stock · 19,897 shares Expires 2027-03-27 F1 · derivative.exercise_date: The option becomes exercisable in three annual installments of 4,974 shares on March 27, 2018, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-17-012981 · doc1.xml · derivative · entry 5 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 6,000 shares Expires 2018-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-17-012981 · doc1.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $45.92 | $459,200.00 |
DisclosureSEC source: 0001140361-17-012981 · doc1.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 6,000 | $0.10 | $600.00 |
DisclosureSEC source: 0001140361-17-012981 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 8,000 | $0.10 | $800.00 |
DisclosureSEC source: 0001140361-17-012981 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 20:37 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-17-008713 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 20:37 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $42.60 | $426,023.00 |
DisclosureSEC source: 0001140361-17-008713 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $42.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 20:37 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-17-008713 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 19:58 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-17-002755 · doc1.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 19:58 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 5,388 | $48.02 | $258,723.68 |
DisclosureSEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.13, inclusive. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 19:58 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 4,612 | $47.40 | $218,595.89 |
DisclosureSEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,388 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 19:58 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 16:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-16-090631 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 16:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $40.12 | $401,223.00 |
DisclosureSEC source: 0001140361-16-090631 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.94 to $40.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 16:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-16-090631 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 19:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 30,000 | $40.88 | $1,226,337.00 |
DisclosureSEC source: 0001140361-16-089444 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.56 to $41.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 13:31 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-16-087735 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 13:31 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $41.11 | $411,121.00 |
DisclosureSEC source: 0001140361-16-087735 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.805 to $41.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 13:31 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-16-087735 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 15:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-16-083371 · doc1.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 15:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 197 | $36.16 | $7,123.52 |
DisclosureSEC source: 0001140361-16-083371 · doc1.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 15:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,803 | $35.35 | $346,562.52 |
DisclosureSEC source: 0001140361-16-083371 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,197 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 15:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-16-083371 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 20:11 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001140361-16-080483 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 14,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 20:11 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $35.03 | $350,314.00 |
DisclosureSEC source: 0001140361-16-080483 · doc1.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.83 to $35.2275, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 20:11 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 14,000 | $0.10 | $1,400.00 |
DisclosureSEC source: 0001140361-16-080483 · doc1.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.